Thyroid imaging
Appearance
Ultrasound
[edit | edit source]- Advantages
- Most accurate visualisation of thyroid nodular disease
- Information about overall thyroid size and vascularity
- Presence of cervical lymphadenopathy (good for lateral neck, not as good for central neck compartment)
- Can be used to localise parathyroid disease
- Normally homogenously echogenic, with a uniform echotexture
Nuclear scintigraphy
[edit | edit source]- Either technetium-99m pertechnetate or a radiolabelled iodine nuclide
- The technetium-99 - pertechnetate complex is taken up by the thyroid instead of iodine, and patients can then be imaged to show the distribution of active thyroid tissue
- Normally symmetrical uptake bilaterally
- Divides nodules into 'hot' or 'cold'
- Cold nodules have a 15% risk of malignancy, whereas hot nodules are generally benign
- Indications
- In hyperthyroidism to differentiate between Graves and solitary toxic adenoma/TMNG
- Differentiated thyroid cancer - check for recurrent or metastatic disease
Iodine nuclide scan
[edit | edit source]- I-123 is the diagnostic scan to assess malignancies for uptake on I-131
- I-131 is the therapeutic vehicle for treating malignancies
- Both done as whole-body scan
CT
[edit | edit source]- Anatomical information - substernal goitre and advanced thyroid cancer
- IV contrast in thyroid disease
- IV contrast expands the iodine blood pool, which is subsequently taken up by the thyroid
- Technetium studies won't be useful until this is cleared, because the thyroid won't take up technetium if it is already engorged with iodine
- Iodine generally cleared 4-8 weeks after contrast administration
- IV contrast can also worsen/precipitate hyperthyroidism in Graves or toxic nodules or hyperthyroid phase of Hashimoto's, but only really if it's poorly-controlled - it's ok if they have normal TFTs, and generally also ok if they're on treatment. This hyperthyroid storm would occur some weeks after administration.
PET-FDG
[edit | edit source]- Similar uptake to surrounding muscle in the normal thyroid
- Not routinely used, but useful in some cancers
Sestamibi-SPECT
[edit | edit source]- Uses Tc-99m-sestamibi
- Differential uptake and retention of radiotracer in mitochondria-rich cells of metabolically active tissues (sestamibi is a chemical that gets picked up by cells with lots of mitochondria, like heart and parathyroid)
- Hyperfunctioning parathyroid glands preferentially take up and retain the tracer - best demonstrated on the 2 hour scan
- Sensitivity 79% for adenoma, 44% for multi-gland disease
- Addition of ultrasound improves sensitivity further
4D-CT
[edit | edit source]- Four dimensions - non-con, early arterial (45 seconds), delayed (75 seconds), and an assessment of the change in perfusion over time
- Time is the fourth dimension here - the number of phases is not necessarily four
- Parathyroid adenoma has lower attenuation compared to thyroid on non-con (45 HU compared to 90), rapid enhancement with maximum attenuation values of about 130HU in arterial, and then rapid washout of contrast material in the delayed phase
- Conversely, normal thyroid and parathyroid tissue progressively enhances through the phases
- Sensitivity 81-89% for adenoma, 55% for multi-gland disease
- Particularly useful for small adenomas and abnormal glands or in re-operative cases